The text starts here.

News Release

FOR IMMEDIATE RELEASE
Aug 25, 2000

NOTICE OF BUSINESS RESULTS FORECAST REVISION
FOR THE INTERIM AND FISCAL YEAR PERIOD FOR THE YEAR ENDING MARCH 2001

Listed Stock Name: Eisai Co., Ltd.
Head Office Location: 4-6-10 Koishikawa Bunkyo-ku, Tokyo
Code: 4523
Listed Locations: First Sections of the Tokyo Stock Exchange & the Osaka Securities Exchange
Inquiries: Mr. Isao Okabayashi
In Charge of Public Relations & Legal Affairs
Member, Board of Directors
Phone 81-3-3817-5190

Notice of Business Results Forecast Revision
For the Interim and Fiscal Year Period for the Year Ending March 2001

For the Fiscal Year ending March 2001 (April 1, 2000 - March 31, 2001), the non-consolidated and consolidated business results forecast were made on May 23, 2000 and the tables below note a revision to those forecasts.

I1. Consolidated business results forecast revision for the interim period of the fiscal year ending March 2001. ( April 1, 2000 - September 30, 2000)
Unit: Yen Millions, %percent
Net Sales Ordinary Income Net Income
May 2000 Forecast (A) yen163,000 yen20,000 yen3,000
Revised Forecast (B) yen176,000 yen27,500 yen7,000
Increase/Decrease (B) - (A) yen13,000 yen7,500 yen4,000
%percent Increase/Decrease 8.0 %
percent
37.5 %
percent
133.3 %
percent

Note: Operating Income is forecast to be yen27,000 million.

  I2I. Consolidated business results forecast revision for the interim period of the fiscal year ending March 2001. ( April 1, 2000 - September 30, 2000)
Unit: Yen Millions, %percent
Net Sales Ordinary Income Net Income
May 2000 Forecast (A) yen116,000 yen19,000 yen2,000
Revised Forecast (B) yen130,000 yen29,500 yen7,000
Increase/Decrease (B)-(A) yen14,000 yen10,500 yen5,000
%percent Increase/Decrease 12.1 %
percent
55.3 %
percent
250.0 %
percent
Interim Results for Year Ended Ended March 2000 yen113,922 yen19,399 yen3,676

Note: Operating Income is forecast to be yen29,000 million.

  III3. Consolidated business results forecast revision for the fiscal year ending March 2001. ( April 1, 2000 - March 31, 2001)
Unit: Yen Millions, %percent
Net Sales Operating Income Ordinary Income Net Income
May 2000 Forecast (A) yen340,000 yen41,000 yen41,000 yen12,500
Revised Forecast (B) yen358,000 yen50,000 yen51,000 yen19,000
Increase/Decrease (B) - (A) yen18,000 yen9,000 yen10,000 yen6,500
%percent Increase/Decrease 5.3 %
percent
22.0 %
percent
24.4 %
percent
52.0 %
percent
Business Results for the Year Ended Ended March 2000 yen302,470 yen37,132 yen36,858 yen11,275

  IV. Non-consolidated business results forecast revision for the fiscal year ending March 2001. ( April 1, 2000 - March 31, 2001)
Unit: Yen Millions, %percent
Net Sales Operating Income Ordinary Income Net Income
May 2000 Forecast (A) yen235,000 yen36,000 yen36,000 yen10,000
Revised Forecast (B) yen252,000 yen47,000 yen47,500 yen14,500
Increase/Decrease (B) - (A) yen17,000 yen11,000 yen11,500 yen4,500
%percent Increase/Decrease 7.2 %
percent
30.6 %
percent
31.9 %
percent
45.0 %
percent
Business Results for the Year Ended Ended March 2000 yen230,597 yen38,740 yen38,431 yen12,045

  V. The reasons for the revision are noted below.

Sales of prescription pharmaceuticals in Japan have been better than the expectations of the May forecast; and sales of Aricept and Pariet (Aciphex in the U.S) have continued to expand in the U.S. and Europe. In addition, the yen has depreciated from the forecast exchange rate ($1U.S.=yen105) leading to expected increases in sales, and profits in comparison to the previously announced forecast.

In addition, in the non-consolidated forecast an evaluation loss of subsidiary stock will be included due to the adoption of the current value method accounting.